13-Mar-2026
Diversified Healthcare Trust Announces Fourth Quarter 2025 Results
Business Wire (Mon, 23-Feb 4:15 PM ET)
Business Wire (Tue, 27-Jan 8:00 AM ET)
Diversified Healthcare Trust Announces 2025 Dividend Allocation
Business Wire (Tue, 20-Jan 4:30 PM ET)
Diversified Healthcare Trust Announces Quarterly Dividend on Common Shares
Business Wire (Thu, 15-Jan 8:00 AM ET)
Market Chameleon (Mon, 5-Jan 6:19 AM ET)
Diversified Healthcare Trust Provides Business Update
Business Wire (Mon, 5-Jan 8:00 AM ET)
Diversified Healthcare Trust is a real estate investment trust that focuses on healthcare-related properties, including life science estates, medical offices, and senior living communities. It acquires and owns properties and is engaged in the development and implementation of medical services and technologies. The company has two reportable segments: SHOP (Senior Housing Operating Portfolio) and Medical Office and Life Science Portfolio. The SHOP segment includes managed senior living communities providing residential living and care services. The Medical Office and Life Science Portfolio segment consists of properties leased to medical providers and biotechnology laboratories. It generates the majority of its revenue from the SHOP segment.
Diversified Healthcare Trust - Common Shares Of Beneficial Interest trades on the NASDAQ stock market under the symbol DHC.
As of March 13, 2026, DHC stock price declined to $7.23 with 2,739,385 million shares trading.
DHC has a beta of 0.27, meaning it tends to be less sensitive to market movements. DHC has a correlation of 0.01 to the broad based SPY ETF.
DHC has a market cap of $1.75 billion. This is considered a Small Cap stock.
Last quarter Diversified Healthcare Trust - Common Shares Of Beneficial Interest reported $380 million in Revenue and $.09 earnings per share. This fell short of revenue expectation by $-15 million and exceeded earnings estimates by $.15.
In the last 3 years, DHC traded as high as $7.66 and as low as $.80.
The top ETF exchange traded funds that DHC belongs to (by Net Assets): VNQ, VTI, IWM, FNDA, IWN.
DHC has outperformed the market in the last year with a price return of +182.9% while the SPY ETF gained +21.4%. DHC has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +54.4% and +7.0%, respectively, while the SPY returned -2.6% and -3.5%, respectively.
DHC support price is $7.11 and resistance is $7.73 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that DHC shares will trade within this expected range on the day.